Peter Grube-Pagola

The TOP ‐ GERD Trial: Comparative Efficacy of Tegoprazan Versus Pantoprazole in the Treatment of Erosive Oesophagitis in a Non‐Asian Population

ABSTRACT Background Potassium‐competitive acid blockers provide rapid and sustained acid suppression, but tegoprazan has not been studied in non‐Asian populations. Aim To compare the efficacy and safety of tegoprazan 50 mg once daily with pantoprazole 40 mg once daily for healing...